Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Direct Meds vs TMates

Direct Meds and TMates both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Direct Meds logo

Direct Meds

6.4
★★★☆☆3.2/5

Best for: compounded semaglutide at $249/month

Visit Direct Meds →
VS
TMates logo

TMates

7.6
★★★★☆3.8/5

Best for: coaching inside the $249/month rather than sold separately

Visit TMates →

If you are choosing between Direct Meds and TMates, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. TMates leads our six-part score, 7.6 to 6.4. One of the two has an FDA warning letter on record, covered below.

Direct Meds vs TMates price

Direct Meds and TMates start at the same figure, $249 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $249 a month; tirzepatide is cheaper at TMates ($297 a month vs $299 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

Direct Meds does not publish where it ships, and TMates lists 50 states.

Pricing

Direct Meds

SublingualCompounded
$249/mo
semaglutide

'As low as $249' per month, on a 90-day supply billed monthly; some doses run as low as $237/mo.

InjectionCompounded
$297/mo
semaglutide

'As low as $297' per month ($9.58 a day), an 84-day three-pack billed monthly.

SublingualCompounded
$299/mo
tirzepatide

'As low as $299' per month ($9.65 a day) on a 90-day supply billed monthly. Down from $399 earlier.

InjectionCompounded
$399/mo
tirzepatide

'As low as $399' per month ($12.87 a day).

TMates

Semaglutide 1-month plan (same price all doses, 0.25–2.4mg)Compounded
$249/mo
semaglutide

1 month $249; 3 months $217/mo ($650, save 13%); 6 months $175/mo ($1,050, save 30%); 12 months $158/mo ($1,900, save 37%). Injectable or oral at the same price. Includes medication and ongoing support, free shipping, cancel anytime.

Tirzepatide 1-month plan (same price all doses, 2.5–15mg)Compounded
$297/mo
tirzepatide

1 month $297; 3 months $267/mo ($800, save 10%); 6 months $217/mo ($1,299, save 27%); 12 months $167/mo ($1,999, save 44%). Injectable or oral at the same price.

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

TMates' price also covers coaching, which Direct Meds does not claim.

Direct Meds is silent on lab work and coaching.

TMates is silent on lab work.

Direct Meds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

TMates

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, TMates scores 7.6 and Direct Meds 6.4 out of 10.

TMates is stronger on trust & safety (7.5 vs 3.5), accessibility (10.0 vs 5.0) and support (8.5 vs 7.0).

Value, effectiveness and user experience are within half a point.

How we score

Direct Meds

6.4/10

Overall

TMates

7.6/10

Value25%

3.7A
vs
B
3.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

3.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

FDA warning letters

The FDA sent Direct Meds a warning letter dated September 9, 2025 (letter 716822), and it is still open.

TMates has no FDA warning letter on record with us.

Features & Coverage

FeatureDirect MedsTMates
Starting Price$249/mo$249/mo
Features✓5 features4 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name——
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Direct Meds

The FDA sent Direct Meds a warning letter in September 2025 over misleading marketing, and customers have reported a documented pattern of unexpected 3-month commitment charges. We list the company with both disclosed in full; read the warnings and the cons first. Its products are compounded semaglutide and tirzepatide, sold from Utah in injection and sublingual form.

Read our full Direct Meds review →

About TMates

TMates is a Miami-based telehealth platform selling compounded semaglutide at $249/mo and compounded tirzepatide at $297/mo across all 50 states plus Puerto Rico. The model is messaging-first, with independent licensed prescribers and third-party compounding pharmacies.

Read our full TMates review →

Pros & Cons

Direct Meds

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Direct Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

TMates

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves all 50 states
  • We found no FDA warning letters issued to TMates

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $297 a month, 19% above the $250 median for compounded tirzepatide across the sellers we compare
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Direct Meds

Direct Meds is where we would start, above all for compounded semaglutide at $249/month. TMates fits better if coaching inside the $249/month rather than sold separately is your priority.

Choose Direct Meds if…

You want compounded semaglutide at $249/month and an opening price near $249 a month.

Choose TMates if…

You want coaching inside the $249/month rather than sold separately and an opening price near $249 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.0

CoreAge Rx

Semaglutide at $99/month, 48% below the typical price

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

6.4

ShedRx

Oral orforglipron alongside the injectables

Direct Meds vs TMates: FAQ

Neither on the entry price: Direct Meds and TMates both start at about $249 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Direct Meds does not publish where it ships; TMates lists 50 states. Confirm your state before paying.
Both include the clinician visit, the medication itself and shipping. Only TMates includes coaching.
Direct Meds has an open FDA warning letter from September 9, 2025. TMates has none.
Direct Meds pays us a commission on sign-ups through our links; TMates does not. Scores are computed the same way for both.

Or see the full category ranking.